(Tôi có Cô Cháu bị ung thứ vú mất cách đây 2 năm , những tháng cuối rất tội nghiệp vì phải nằm sấp để bớt đau nhưng lại nghẹt thở vì phổi bị chèn ép).
Avastin fights early breast cancer in 2 studies: Will it be re-approved?
(Credit: AP Photo/Genentech Inc.)
(CBS/AP) Is Avastin back in running for breast cancer treatment?
The FDA revoked Avastin's approval for treating breast cancer in November 2011, saying the drug didn't extend life and could cause dangerous side effects. But two new studies released this week show the drug made tumors disappear in women with early stages of breast cancer.
The studies' surprising results may reopen the debate about the value of Avastin for breast cancer. These were the first big tests of the drug for early breast cancer, and doctors were cautiously excited that it showed potential.